Replies to post #66026 on PharmaCyte Biotech Inc (PMCB)

[TheBestInvest]

"This new patent application, while it does include our pancreas cancer therapy, should really be viewed as an opportunity to dramatically broaden PharmaCyte’s ability to protect our therapy for all malignant tumors for the next 20 years.”

Looks like waggs has bigger plans after we get PC FDA approval...

This PR looks a little better than his past few.

[$Pistol Pete$]

$PMCB This is a brand new patent to protect everything "cancer" and it will be PharmaCyte's patent. The good news is with the filing... the pancreatic cancer therapy is now protected for the next year... (where the other patents are set to expire on March 27) while the company works with the USTPO to get this patent approved... and it will give PharmaCyte a fresh clock of 20 years on everything cancer.

http://globenewswire.com/news-release/2017/03/22/943094/0/en/PharmaCyte-Biotech-Strengthens-Protection-of-Cancer-Therapy-with-Patent-Filing.html

[Ciab]

As expected...

Moving forward with old patent, with "rewritten" design, IS NOT possible/allowed ....so, due to the suggested changes by the FDA the new filing is necessary.

The new patent application, or "provisional", is a one year time clock that allows them ample time to redesign/rewrite and perfect.

This is great news.

GoPMCB!!! Go KW!!!